Physician profile
Matthew A Mann
NPI 1831583244
$17,906.53
in general payments reported to CMS, 2019-2025
27 companies · $2,958 in 2025
The $2,958 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,470 · 2020: $3,712 · 2021: $1,453 · 2022: $2,018 · 2023: $1,060 · 2024: $236 · 2025: $2,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,745 · Travel and Lodging: $1,509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,745.12 |
| Travel and Lodging | $1,508.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $6,375.72 | 2019-2020 | |
| Stryker Corporation | $3,664.87 | 2019-2025 | Mako, Infinity, Insignia |
| Prodigy Surgical Distribution, INC. | $3,144.95 | 2019-2025 | |
| Medacta USA, INC. | $1,446.20 | 2020-2025 | Gmk Sphere, Spherika |
| Smith+Nephew, INC. | $513.38 | 2020-2025 | Cadence, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Depuy Synthes Sales INC. | $421.00 | 2019-2025 | |
| Nevro Corp. | $381.61 | 2019-2021 | |
| Treace Medical Concepts, INC. | $365.45 | 2023-2025 | |
| Organogenesis INC. | $246.65 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $203.70 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Davol INC. | $149.62 | 2023 | |
| Advanced Oxygen Therapy INC. | $124.99 | 2022 | |
| Misonix INC | $124.00 | 2021 | |
| Kci USA, INC. | $122.92 | 2019 | |
| Integra Lifesciences Corporation | $122.21 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $115.01 | 2019 | |
| Horizon Therapeutics Plc | $106.82 | 2020 | |
| Orthalign INC | $65.28 | 2023 | Orthalign Plus |
| Pacira Therapeutics, INC. | $35.82 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $26.26 | 2025 | |
| Orthofix Medical, INC. | $23.83 | 2019-2021 | |
| Solventum Corporation | $22.77 | 2024 | Prevena |
| Sanara Medtech INC. | $21.75 | 2025 | Celleraterx |
| Vericel Corporation | $21.62 | 2022 | |
| Highridge Medical LLC | $20.54 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ferring Pharmaceuticals INC. | $20.00 | 2024 | Euflexxa |
| Avanos Medical | $19.56 | 2024 | Grpro 2.1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.